RituximabCOVID-19: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1836卷 / 1期

关键词：

D O I：

10.1007/s40278-021-88505-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：686 / 686

相关论文

共 50 条

[41] Infliximab/rituximabCOVID-19 infection: 10 case reports
Reactions Weekly, 2022, 1895 (1) : 221 - 221
[42] Ocrelizumab/rituximabCOVID-19 infection
Reactions Weekly, 2024, 2005 (1) : 663 - 663
[43] Bendamustine/obinutuzumab/rituximabCOVID-19 infection and prolonged COVID-19 virus positivity: case report
Reactions Weekly, 2022, 1922 (1) : 134 - 134
[44] Methotrexate/prednisone/rituximabCOVID-19 pneumonia: 3 case reports
Reactions Weekly, 2021, 1872 (1) : 307 - 307
[45] Methotrexate/prednisolone/rituximabCOVID-19 pneumonia: 2 case reports
Reactions Weekly, 2021, 1856 (1) : 267 - 267
[46] COVID-19-vaccines/prednisolone/rituximabCOVID-19 pneumonia and lack of efficacy: case report
Reactions Weekly, 2022, 1925 (1) : 190 - 190
[47] Immunosuppressants/rituximabCOVID-19 infection: 23 case reports
Reactions Weekly, 2022, 1913 (1) : 254 - 254
[48] Fingolimod/rituximabCOVID-19 and reduced humoral immunity: 3 case reports
Reactions Weekly, 2023, 1968 (1) : 143 - 143
[49] Covid-19-vaccine/rituximabCOVID-19 infection and lack of efficacy caused by drug interactions: case report
Reactions Weekly, 2021, 1879 (1) : 114 - 114
[50] Ciclosporin/everolimus/rituximabCOVID-19, Epstein-Barr virus infection and COVID-19 reinfection: case report
Reactions Weekly, 2021, 1885 (1) : 147 - 147

← 1 2 3 4 5 →